We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Stago Launches New My Qualiris QC Website for Brand-New User Experience

By LabMedica International staff writers
Posted on 28 Jan 2022

Image: My Qualiris QC (Photo courtesy of Stago)

Image: My Qualiris QC (Photo courtesy of Stago)

Stago (Paris, France) has launched its new My Qualiris QC website which provides a brand-new user experience with a 24/7 accessible web-application where the results of a user’s network are only a few clicks away.

My Qualiris QC provides an easy-to-use and comprehensive External Quality Assessment service that will meet the daily and special coagulation testing needs of laboratories. To optimize the quality approach of laboratories, Stago had introduced the My Qualiris QC program more than 10 years ago. Built on Stago's expertise in hemostasis, My Qualiris QC carries out complete comparisons designed in accordance to the NF EN ISO/IEC 17043 standard to ensure reliability of results.

My Qualiris QC estimates global performance through an extensive multi-level comparison to ensure system accuracy. Stago’s color-coded reports and alerts are easy to interpret, and they include haemostasis-specific indicators. The new My Qualiris QC website allows laboratories to manage different user profiles, submit results and consult the available reports whenever they want. The dedicated, secured, multilingual website also allows laboratories to archive their results for five years and download their participation certificate for audits.

Related Links:
Stago: My Qualiris QC

Visit expo >

Gold Member

Automatic Hematology Analyzer

CF9600

Online QC Software
Acusera 24•7

Manual Pipetting Aid

Pipette Controllers macro

Electrolyte Analyzer

CBS-4000 (CBS-400)

Latest Hematology News

Channels

Clinical Chemistry

view channel

FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis

Chronic liver disease contributes substantially to mortality, and clinicians routinely screen adults with compensated cirrhosis for varices to prevent bleeding. However, endoscopy is invasive and reso... Read more

Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes

Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read more

Blood Test Detects More High-Risk Prostate Cancers Than PSA

Prostate cancer is one of the most common malignancies in men, and screening often struggles to distinguish indolent tumors from clinically significant disease. Prostate-specific antigen (PSA) testing... Read more

Rapid Blood Test Aids Diagnosis of Acute Ischemic Stroke

Rapid and accurate differentiation of stroke types remains a persistent challenge in emergency medicine, particularly because early imaging can miss ischemic events that require time-sensitive intervention.... Read more

Molecular Diagnostics

view channel

Interpretable AI Tool Improves Prediction of Immunotherapy Response

Immune checkpoint inhibitors are standard treatment options across many cancers, but only a subset of patients benefit, making patient selection difficult. Because predictive biomarkers remain limited,... Read more

At-Home PCR Test Detects Flu and COVID-19 in 30 Minutes

Respiratory infections such as COVID-19 and influenza continue to send large numbers of patients to urgent care, where timely diagnosis can guide appropriate therapy. With growing consumer use of at-home... Read more

New Sequencing Platform Delivers Same-Day Whole-Genome Results

Roche (Basel, Switzerland) has introduced AXELIOS 1, a next‑generation single‑molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology. The system is positioned to combine... Read more

Image: New findings show that the transcription factor IRF2 has both pathogenic and prognostic significance in multiple myeloma (Image Credit: Shutterstock)

New Molecular Marker Helps Predict Multiple Myeloma Prognosis

Multiple myeloma is a bone marrow cancer marked by resistance to therapy and frequent relapse, complicating long-term disease control. Better molecular markers are needed to refine risk assessment and... Read more

Immunology

view channel

Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms

Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more

Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV

Undiagnosed HIV continues to drive avoidable morbidity and transmission, with many people identified only after substantial immune damage has occurred. In England, about one in 20 people living with HIV... Read more

Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission

Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read more

New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease

Autoimmune disorders arise when immune responses target self-antigens, driving chronic inflammation and long-term morbidity. In primary Sjögren disease, inflammation of salivary and lacrimal glands leads... Read more

Microbiology

view channel

Rapid Gastrointestinal PCR Panels Deliver One-Hour Results

Acute infectious gastroenteritis remains a major cause of illness worldwide, especially in young children, older adults, and immunocompromised patients. Nonspecific symptoms such as diarrhea, vomiting,... Read more

H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention

Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more

Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer

Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read more

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Pathology

view channel

AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers

Immunotherapy has transformed care for select malignancies, yet predicting which patients with rare cancers are most likely to benefit remains challenging. Clinicians often have only limited biomarkers... Read more

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping

Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read more

Study Highlights Biomarker Testing Delays in Lung Cancer Care

Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read more

Stain-Free Imaging Platform Matches Standard Cancer Pathology

Histopathology underpins cancer diagnosis, but turnaround times and inter-laboratory variability can limit timely, consistent interpretation. Conventional staining relies on chemical dyes and multiple... Read more

Technology

view channel

National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care

Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read more

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines

Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more

Agentic AI Platform Supports Genomic Decision-Making in Oncology

Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more

Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps

Colorectal cancer screening is a longstanding preventive priority, yet participation and follow-up remain uneven across patient groups. Safety‑net primary care settings often face barriers that limit screening... Read more

Industry

view channel

Eurobio Scientific Completes Acquisition of CareDx Lab Products Division

Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more

Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia

Colombia remains a high-priority setting for tuberculosis, with a growing need for diagnostics that complement existing testing strategies and improve access to earlier diagnosis. Solutions that function... Read more

Partnership Integrates Automated DNA Extraction with Single-Molecule Digital PCR

Countable Labs (Palo Alto, CA, USA) and Promega (Madison, WI, USA) have entered a co-marketing agreement that integrates the Promega Maxwell System for nucleic acid extraction with Countable Labs’ Countable... Read more

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Agilent Technologies has completed its acquisition of Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners LLP. Biocare is now part of Agilent’s Life Sciences and Diagnostics... Read more